A 2019 study identified TNAP in a genome-wide meta-analysis looking for CAVD susceptibility genes (34), supporting a role of TNAP in CAVD pathogenesis. The gene discussed is ALPL; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.